Topics and Expertise: structure-based drug design

Shoichet receives DeLano Award for Computational Biosciences

Thu Dec 1, 2016
DOCK graphic
Robert Rizzo

Graphic depiction of a typical DOCK setup used toward the discovery of a potential disease inhibitor—in this case, testing compounds for binding to an HIV protein.

Brian Shoichet, PhD, faculty member in the School’s Department of Pharmaceutical Chemistry, has been named the 2017 recipient of the DeLano Award for Computational Biosciences.

Shoichet co-led research develops safer, potentially less addictive painkiller

Wed Aug 17, 2016
Shoichet
Elisabeth Fall

Brian Shoichet, PhD

Research co-led by UCSF School of Pharmacy faculty member Brian Shoichet, PhD, has developed a new opioid drug candidate that blocks pain as effectively as morphine in mice, without triggering dangerous side effects, and also apparently without the addictive properties of current prescription...

Reflection: 30 years of top NIH funding for UCSF School of Pharmacy

Wed Dec 22, 2010
people discuss research results

Kathy Giacomini, PhD (center), co-chair of the Department of Bioengineering and Therapeutic Sciences, discusses research results in the lab with postdocs Sook Wah Yee (left), and Amber Dahlin (right).

Table of contents


Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support